MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Impulse Control Disorder and medication management in Patients with Early-Onset Parkinson’s Disease

    J. Jacobson, K. Ghoniem, A. Mullan, P. Turcano, C. Stang, E. Camerucci, C. Piat, J. Bower, R. Savica (Rochester, USA)

    Objective: To assess the usage frequency of dopamine agonists (DA), the prevalence of impulse control disorder (ICD) in patients with Early-onset Parkinson’s Disease (EOPD), and…
  • 2023 International Congress

    Comparative Assessment of Gait and Balance in Patients with Parkinson’s Disease and Normal Pressure Hydrocephalus

    K. Akar, H. Youssef, ö. öztop çakmak, M. Samancı, S. Ertan, A. Vural (Istanbul, Turkey)

    Objective: Parkinson's disease (PD) and normal pressure hydrocephalus (NPH) cause gait and balance problems, which often lead to falls. The mechanisms responsible for gait and…
  • 2023 International Congress

    Transcriptomic profiling in DYT1 dystonia: unravelling pathogenic pathways.

    N. Setó-Salvia, S. Wrigley, P. Cullinane, J. Hamilton, C. Arber, U. Yaman, H. Houlden, D. Salih, TT. Warner (London, United Kingdom)

    Objective: The aim of this project is to investigate post-mortem brain tissues, iPSC and iPSC-derived neurons from controls and patients with DYT1 dystonia to find…
  • 2023 International Congress

    Social and gender inequity on overall survival and access to deep brain stimulation in Parkinson disease patients in Colombia

    C. Pantoja-Ruiz, D. Rosselli (Bogota, Colombia)

    Objective: Describe discrepancies on survival and access to DBS in PD in Colombia by gender and affiliation regime. Background: Lower socioeconomic status (SES) has been…
  • 2023 International Congress

    Post-hypoxic myoclonus after bilateral pallidal stimulation: A case report

    S. Shah, J. Jimenez-Shahed (New York, USA)

    Objective: To describe the effect of bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) for post-hypoxic myoclonus and associated local field potential (LFP) activity.…
  • 2023 International Congress

    Parkinson’s disease in patients with Gaucher’s disease – causation or association?

    B. Pandey (Tirupati, India)

    Objective: To do a systematic review to find the risk of Parkinson's disease in patients with Gaucher’s disease. Background: Parkinson's disease (PD) is the second…
  • 2023 International Congress

    Effects on voice sound level and brain connectivity after HiCommunication: a novel speech and communication treatment for Parkinson’s disease

    H. Steurer, F. Albrecht, A. Razi, J. Körner Gustafsson, E. Franzén, E. Schalling (Stockholm, Sweden)

    Objective: This study aimed to evaluate the clinical relevance of effects on voice sound level (Lv) as well as brain connectivity using resting-state functional MRI…
  • 2023 International Congress

    Single-center experience of deep brain stimulation (DBS) surgery in Malaysia

    AM. Dy Closas, AH. Tan, JL. Lim, YW. Tay, A. Ahmad-Annuar, K. Lohmann, C. Klein, CY. Cham, KA. Muthusamy, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: We aimed to characterize the DBS cohort and outcomes at a quaternary medical centre in Malaysia. Background: Deep brain stimulation s an established treatment…
  • 2023 International Congress

    Positive and negative myoclonus monitoring using ambulatory surface EMG and 3D accelerometry

    S. Rissanen, A. Sinokki, J. Hyppönen, L. Säisänen, K. Silvennoinen, P. Karjalainen, E. Mervaala, Z. Hadj-Allal, R. Kälviäinen (Kuopio, Finland)

    Objective: An objective method is presented for monitoring of positive and negative myoclonus using wearable surface EMG and 3D accelerometry in clinical and home settings.…
  • 2023 International Congress

    Extent of cognitive impairment in Parkinson`s disease with Covid-19

    B. Muminov, E. Abduqodirov, R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: To study of the extent of cognitive impairment in PD patients with Covid-19. Background: Covid-19 may aggravate the clinical course of Parkinson's disease (PD)…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley